Hangzhou AGS MedTech Co. Ltd. A Asset Resilience Ratio
Hangzhou AGS MedTech Co. Ltd. A asset resilience ratio. Hangzhou AGS MedTech Co. Ltd. A (688581) has an Asset Resilience Ratio of 18.80% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688581 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Asset resilience ratio of Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025. This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. See Hangzhou AGS MedTech Co. Ltd. A free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Hangzhou AGS MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Hangzhou AGS MedTech Co. Ltd. A's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥507.20 Million | 18.8% |
| Total Liquid Assets | CN¥507.20 Million | 18.80% |
Asset Resilience Insights
- Good Liquidity Position: Hangzhou AGS MedTech Co. Ltd. A maintains a healthy 18.80% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hangzhou AGS MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Hangzhou AGS MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Hangzhou AGS MedTech Co. Ltd. A Asset Resilience Ratio by Year (2021–2025)
Hangzhou AGS MedTech Co. Ltd. A asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Hangzhou AGS MedTech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.13% | CN¥592.42 Million ≈ $86.69 Million |
CN¥2.68 Billion ≈ $391.68 Million |
-4.19pp |
| 2024-12-31 | 26.32% | CN¥671.22 Million ≈ $98.22 Million |
CN¥2.55 Billion ≈ $373.11 Million |
+22.79pp |
| 2023-12-31 | 3.54% | CN¥82.42 Million ≈ $12.06 Million |
CN¥2.33 Billion ≈ $341.11 Million |
-8.09pp |
| 2022-12-31 | 11.63% | CN¥55.01 Million ≈ $8.05 Million |
CN¥473.13 Million ≈ $69.23 Million |
+11.31pp |
| 2021-12-31 | 0.32% | CN¥1.09 Million ≈ $159.70K |
CN¥341.99 Million ≈ $50.04 Million |
-- |
About Hangzhou AGS MedTech Co. Ltd. A
Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more